Home Tools
Log in
Cart

Search Result

Search Results for " c-met/hgfr "

Targets

58

Compounds

1

Natural Products

17

Recombinant Proteins

Cat No. Product Name Synonyms Targets
T7900 BAY-474 c-Met/HGFR
BAY-474 is an inhibitor of tyrosine-protein kinase c-Met. It acts as an epigenetics probe
T2293 SGX-523 Raf , p38 MAPK , c-Met/HGFR , Bcr-Abl
SGX-523 is a selective Met inhibitor (IC50: 4 nM), no inhibitory to Abl, BRAFV599E, p38α, and c-Raf.
T6094 MK-2461 MK2461 c-Met/HGFR
MK-2461 is a novel ATP-competitive multitargeted inhibitor of activated c-Met with a mean IC50 of 2.5 nM.
T5349 SCR-1481B1 c-Met inhibitor 2 VEGFR , c-Met/HGFR
SCR-1481B1 (c-Met inhibitor 2) has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor
T6095 JNJ-38877605 c-Met/HGFR
JNJ-38877605 is an ATP-competitive c-Met inhibitor (IC50: 4 nM), 600-fold selective for c-Met than 200 other tyrosine and serine-threonine kinases.
T10655 c-Met inhibitor 1 c-Met/HGFR
c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of cancer including glioblastoma, gastric, and pancreatic cancer.
T6154 SU11274 Met Kinase Inhibitor,PKI-SU11274 Apoptosis , VEGFR , FGFR , c-Met/HGFR , CDK , Autophagy
SU11274 (Met Kinase Inhibitor)(IC50=10 nM) is a specific Met inhibitor. It shows no significant effects on PGDFRβ, EGFR or Tie2.
T6378 AMG-458 AMG 458 c-Met/HGFR
AMG-458 is a potent c-Met inhibitor with Ki of 1.2 nM, ~350-fold selectivity for c-Met than VEGFR2 in cells.
T6260 AMG-208 AMG 208 P450 , c-Met/HGFR
AMG-208 is a highly selective c-Met inhibitor with IC50 of 9 nM. Phase 1.
T3274 S49076 FGFR , c-Met/HGFR , TAM Receptor
S49076 is a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3, blocking cellular phosphorylation of MET, AXL, and FGFRs.
T6117 Tivantinib ARQ 197 Apoptosis , c-Met/HGFR
Tivantinib (ARQ 197) is an orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity.
T37596 Terevalefim c-Met/HGFR
Terevalefim (ANG-3777) is an hepatocyte growth factor (HGF) mimetic. Terevalefim selectively activates the c-Met receptor.
TQ0041 Ningetinib Tosylate VEGFR , c-Met/HGFR , TAM Receptor
Ningetinib Tosylate is an orally bioavailable tyrosine kinase inhibitor with IC50s of <1.0, 1.9 and 6.7 nM for Axl, VEGFR2, and c-Met, respectively.
T2680 NVP-BVU972 c-Met/HGFR
NVP-BVU972 is a selective and potent Met inhibitor with IC50 of 14 nM.
T6128 PHA-665752 PHA 665752,PHA665752 Apoptosis , VEGFR , FGFR , c-Met/HGFR , Bcr-Abl , Autophagy
PHA-665752 is an effective, specific and ATP-competitive c-Met inhibitor (IC50: 9 nM), >50-fold selectivity for c-Met than STKs or RTKs.
T11162 EGFR-IN-8 EGFR , c-Met/HGFR
EGFR-IN-8 can be a promising candidate for further development to target EGFR TKI-resistant NSCLC. EGFR-IN-8 is a dual EGFR and c-Met inhibitor.
T8409 SYN1143 RON-IN-1,AMG-1 c-Met/HGFR
SYN1143 (AMG-1) is a potent inhibitor of human RON and c-Met.In vitro kinase assays showed that compound I is a potent inhibitor of human RON and c-Met with IC50s of 9 and 4 nmol/L, respectively.
T15617 JNJ-38877618 OMO-1 c-Met/HGFR
JNJ-38877618 (OMO-1) is an effective and highly selective inhibitor of Met kinase (IC50s: 2 and 3 nM for wild type and mutant Met, respectively).
T2419 BMS-794833 VEGFR , c-Met/HGFR
BMS-794833 is a potent ATP competitive inhibitor of Met/VEGFR2; a prodrug of BMS-817378.
T13194 CSF1R-IN-2 c-Fms , c-Met/HGFR , Src
CSF1R-IN-2 is an oral-active SRC, MET and c-FMS inhibitor (IC50s: 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively).
T2496 (Z)-Semaxinib SU5416 VEGFR
(Z)-Semaxinib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor (IC50: 1.23 μM), 20-fold more selective for VEGFR over PDGFRβ, no inhibition for FGFR, InsR, and EGFR. (Z)-Semaxinib is a quinolone derivative w...
T5478 SRI 31215 TFA SRI 31215 c-Met/HGFR
SRI 31215 TFA, a small molecule that acts as a triplex inhibitor of matriptase, hepsin and HGFA and mimics the activity of HAI-1/2, endogenous inhibitors of HGF activation with IC50s of 0.69 μM, 0.65 μM, 0.3 μM,
T5467 SAR125844 SAR125884 Apoptosis , c-Met/HGFR
SAR125844, a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK), for intravenous administration. (IC50 value of 4.2 nmol/L)
T9123 DS-1205 TAM Receptor
DS-1205 is a potent and selective inhibitor of AXL kinase, with an IC50 of 1.3 nM. DS-1205 also inhibits MER, MET, and TRKA, with IC50s of 63, 104, and 407 nM, respectively. DS-1205 can inhibit cell migration in vitro an...
T3209 AMG-337 AMG337 c-Met/HGFR
AMG-337 is an effective and highly specific ATP-competitive MET kinase inhibitor. In enzymatic assays, AMG-337(AMG337) inhibits MET kinase activity (IC50: < 5 nM).
T4332 c-Kit-IN-1 PDGFR inhibitor 1,DCC-2618 c-Met/HGFR , c-Kit
c-Kit-IN-1 (DCC-2618) is an effective inhibitor of c-Met and c-Kit (IC50s<200 nM).
T6907 NPS-1034 NPS1034,NPS 1034 Apoptosis , c-Met/HGFR , TAM Receptor
NPS-1034 is a dual Met/Axl inhibitor with IC50 of 48 nM and 10.3 nM, respectively.
T2676 PF-04217903 c-Met/HGFR
MET Tyrosine Kinase Inhibitor PF-04217903 is an orally bioavailabe, small-molecule tyrosine kinase inhibitor with potential antineoplastic activity.
TQ0219 MK-8033 c-Met/HGFR
MK-8033 is a new and selective dual ATP competitive c-Met/Ron inhibitor (IC50: 1 nM Wt c-Met).
T5414 Glumetinib SCC244 c-Met/HGFR
Glumetinib (SCC244) (SCC 244) is a novel potent and selective inhibitor of c-Met kinase (IC50: 0.42 nM).
T6517 Golvatinib E-7050 VEGFR , c-Met/HGFR
Golvatinib (E-7050) is an orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic ...
T4426 CEP-40783 CEP 40783,RXDX-106 c-Met/HGFR , TAM Receptor
CEP-40783 (RXDX-106) is an effective, specific and orally active AXL/c-Met inhibitor (IC50: 7/12 nM). It also inhibits MER and TYRO3 (IC50: 29/19 nM).
T3455 Merestinib LY2801653 Discoidin Domain Receptor (DDR) , FLT , c-Met/HGFR , ROS , ROS Kinase
Merestinib (LY2801653) is an orally available, small molecule inhibitor of the proto-oncogene c-Met (Ki: 2 nM) with potential antineoplastic activity. Merestinib electively binds to c-Met, thereby inhibiting c-Met phosph...
T10585 Bozitinib CBT-101,PLB-1001 c-Met/HGFR
Bozitinib (PLB-1001) (PLB-1001) is a highly selective inhibitor of the c-MET kinase with blood-brain barrier permeability. Bozitinib binds to the conventional ATP-binding pocket of the tyrosine kinase superfamily.
TQ0021 Ningetinib CT-053,CT053PTSA VEGFR , c-Met/HGFR , TAM Receptor
Ningetinib (CT-053) (CT053PTSA) is an orally bioavailable tyrosine kinase inhibitor with IC50s of <1.0, 1.9 and 6.7 nM for Axl, VEGFR2, and c-Met, respectively.
T9052 XL092 CL-092,JUN04542 VEGFR , c-Met/HGFR , TAM Receptor
XL092 (JUN04542) is an Axl Mer cMet KDR inhibitor for the treatment of Axl and Mer receptor tyrosine kinase- dependent disorders.
T2699 BMS 777607 BMS777607,BMS-777607,BMS 817378 c-Met/HGFR , TAM Receptor
BMS 777607 (BMS 817378) is a Met-related inhibitor for c-Met/Axl/Ron/Tyro3 (IC50: 3.9/1.1/1.8/4.3 nM). BMS-777607 has been investigated for the basic science of Malignant Solid Tumour.
T1661 Crizotinib PF-02341066 c-Met/HGFR , ROS , ALK , Autophagy , ROS Kinase
Crizotinib (PF-02341066) is an ATP-competitive small-molecule tyrosine kinases inhibitor of c-MET (IC50: 8 nM) and ALK (IC50: 20 nM) receptor.
T6351 MGCD-265 analog MGCD-265,Glesatinib Apoptosis , VEGFR , c-Met/HGFR
MGCD-265 analog (Glesatinib) is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity with IC50 of 29 nM and 10 nM for c-Met and VEGFR2, respectively.
T8825 Capmatinib 2HCl.H2O INCB28060 2HCl.H2O,INC-280 2HCl.H2O,NVP-INC280 2HCl.H2O c-Met/HGFR
Capmatinib 2HCl.H2O (NVP-INC280 2HCl.H2O) is an orally bioavailable inhibitor of the proto-oncogene c-Met (HGFR)with potential antineoplastic activity.
T2516 Amuvatinib MP470,HPK 56 Apoptosis , FLT , c-Met/HGFR , c-RET , DNA/RNA Synthesis , PDGFR , c-Kit
Amuvatinib (MP470) is an orally bioavailable synthetic carbothioamide with potential antineoplastic activity.
TQ0210 Savolitinib AZD-6094,Volitinib,HMPL-504 c-Met/HGFR
Savolitinib (Volitinib) (AZD-6094) is an effective, selective, and orally bioavailable c-Met inhibitor (IC50s: 5 nM/3 nM for c-Met/p-Met).
T2054 Altiratinib DCC-2701 VEGFR , Tie-2 , FLT , Trk receptor , c-Met/HGFR
Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist...
T1963 Capmatinib NVP-INC280,INC-280,INCB28060 Apoptosis , c-Met/HGFR
Capmatinib (INCB28060) is an orally bioavailable inhibitor of the proto-oncogene c-Met (HGFR)with potential antineoplastic activity.
T8416 Capmatinib xHCl INCB28060,Capmatinib hydrochloride(free base),INC280 c-Met/HGFR
Capmatinib xHCl (INCB28060) is a potent, orally active, selective, and ATP competitive c-Met kinase inhibitor, potently blocking in vitro kinase activity (IC50 = 0.13 nM) as well as constitutive or HGF-stimulated activit...
T3550 X-376 Ensartinib,X-396 c-Met/HGFR , ALK
X-376 (Ensartinib) is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity. Upon oral administration, X-396 binds to and inh...
T17184 Tyrosine kinase inhibitor c-Met/HGFR , Tyrosine Kinases
Tyrosine kinase inhibitor is a tyrosine kinase inhibitor used in combination with fragmenting aromatic nitrogen compounds as antiproliferative agents.
T4260 Capmatinib 2HCl INC-280 2HCl,INCB28060 2HCl c-Met/HGFR
Capmatinib 2HCl (INC-280 2HCl) is a novel, ATP-competitive inhibitor of c-MET kinase with an IC50 with 0.13 nM.Capmatinib 2HCl exhibits picomolar enzymatic potency and is highly specific for c-MET with more than 10, 000-...
T2586 Cabozantinib XL184,BMS-907351 Apoptosis , VEGFR , FLT , c-Met/HGFR , c-RET , TAM Receptor , c-Kit
Cabozantinib (XL184) is a multi-targeted tyrosine kinase receptor inhibitor that inhibits VEGFR2, c-Met, Kit, Axl, and Flt3 (IC50=0.035/1.3/4.6/7/11.3 nM). Cabozantinib exhibits both antitumor and antiangiogenic activity...
T22324 Ensartinib hydrochloride Ensartinib dihydrochloride,X-396 dihydrochloride Others , Trk receptor , c-Met/HGFR , ALK
Ensartinib hydrochloride (X-396 dihydrochloride) is a potent new-generation ALK inhibitor with high activity against CNS metastases and a broad range of known crizotinib-resistant ALK mutations. It potently inhibits both...

Compounds

BAY-474
T7900
Synonym:
Target: c-Met/HGFR
SGX-523
T2293
Synonym:
Target: Raf, p38 MAPK, c-Met/HGFR, Bcr-Abl
MK-2461
T6094
Synonym: MK2461
Target: c-Met/HGFR
SCR-1481B1
T5349
Synonym: c-Met inhibitor 2
Target: VEGFR, c-Met/HGFR
JNJ-38877605
T6095
Synonym:
Target: c-Met/HGFR
c-Met inhibitor 1
T10655
Synonym:
Target: c-Met/HGFR
SU11274
T6154
Synonym: Met Kinase Inhibitor,PKI-SU11274
Target: Apoptosis, VEGFR, FGFR, c-Met/HGFR, CDK, Autophagy
AMG-458
T6378
Synonym: AMG 458
Target: c-Met/HGFR
AMG-208
T6260
Synonym: AMG 208
Target: P450, c-Met/HGFR
S49076
T3274
Synonym:
Target: FGFR, c-Met/HGFR, TAM Receptor
Tivantinib
T6117
Synonym: ARQ 197
Target: Apoptosis, c-Met/HGFR
Terevalefim
T37596
Synonym:
Target: c-Met/HGFR
Ningetinib Tosylate
TQ0041
Synonym:
Target: VEGFR, c-Met/HGFR, TAM Receptor
NVP-BVU972
T2680
Synonym:
Target: c-Met/HGFR
PHA-665752
T6128
Synonym: PHA 665752,PHA665752
Target: Apoptosis, VEGFR, FGFR, c-Met/HGFR, Bcr-Abl, Autophagy
EGFR-IN-8
T11162
Synonym:
Target: EGFR, c-Met/HGFR
SYN1143
T8409
Synonym: RON-IN-1,AMG-1
Target: c-Met/HGFR
JNJ-38877618
T15617
Synonym: OMO-1
Target: c-Met/HGFR
BMS-794833
T2419
Synonym:
Target: VEGFR, c-Met/HGFR
CSF1R-IN-2
T13194
Synonym:
Target: c-Fms, c-Met/HGFR, Src
(Z)-Semaxinib
T2496
Synonym: SU5416
Target: VEGFR
SRI 31215 TFA
T5478
Synonym: SRI 31215
Target: c-Met/HGFR
SAR125844
T5467
Synonym: SAR125884
Target: Apoptosis, c-Met/HGFR
DS-1205
T9123
Synonym:
Target: TAM Receptor
AMG-337
T3209
Synonym: AMG337
Target: c-Met/HGFR
c-Kit-IN-1
T4332
Synonym: PDGFR inhibitor 1,DCC-2618
Target: c-Met/HGFR, c-Kit
NPS-1034
T6907
Synonym: NPS1034,NPS 1034
Target: Apoptosis, c-Met/HGFR, TAM Receptor
PF-04217903
T2676
Synonym:
Target: c-Met/HGFR
MK-8033
TQ0219
Synonym:
Target: c-Met/HGFR
Glumetinib
T5414
Synonym: SCC244
Target: c-Met/HGFR
Golvatinib
T6517
Synonym: E-7050
Target: VEGFR, c-Met/HGFR
CEP-40783
T4426
Synonym: CEP 40783,RXDX-106
Target: c-Met/HGFR, TAM Receptor
Merestinib
T3455
Synonym: LY2801653
Target: Discoidin Domain Receptor (DDR), FLT, c-Met/HGFR, ROS, ROS Kinase
Bozitinib
T10585
Synonym: CBT-101,PLB-1001
Target: c-Met/HGFR
Ningetinib
TQ0021
Synonym: CT-053,CT053PTSA
Target: VEGFR, c-Met/HGFR, TAM Receptor
XL092
T9052
Synonym: CL-092,JUN04542
Target: VEGFR, c-Met/HGFR, TAM Receptor
BMS 777607
T2699
Synonym: BMS777607,BMS-777607,BMS 817378
Target: c-Met/HGFR, TAM Receptor
Crizotinib
T1661
Synonym: PF-02341066
Target: c-Met/HGFR, ROS, ALK, Autophagy, ROS Kinase
MGCD-265 analog
T6351
Synonym: MGCD-265,Glesatinib
Target: Apoptosis, VEGFR, c-Met/HGFR
Capmatinib 2HCl.H2O
T8825
Synonym: INCB28060 2HCl.H2O,INC-280 2HCl.H2O,NVP-INC280 2HCl.H2O
Target: c-Met/HGFR
Amuvatinib
T2516
Synonym: MP470,HPK 56
Target: Apoptosis, FLT, c-Met/HGFR, c-RET, DNA/RNA Synthesis, PDGFR, c-Kit
Savolitinib
TQ0210
Synonym: AZD-6094,Volitinib,HMPL-504
Target: c-Met/HGFR
Altiratinib
T2054
Synonym: DCC-2701
Target: VEGFR, Tie-2, FLT, Trk receptor, c-Met/HGFR
Capmatinib
T1963
Synonym: NVP-INC280,INC-280,INCB28060
Target: Apoptosis, c-Met/HGFR
Capmatinib xHCl
T8416
Synonym: INCB28060,Capmatinib hydrochloride(free base),INC280
Target: c-Met/HGFR
X-376
T3550
Synonym: Ensartinib,X-396
Target: c-Met/HGFR, ALK
Tyrosine kinase inhibitor
T17184
Synonym:
Target: c-Met/HGFR, Tyrosine Kinases
Capmatinib 2HCl
T4260
Synonym: INC-280 2HCl,INCB28060 2HCl
Target: c-Met/HGFR
Cabozantinib
T2586
Synonym: XL184,BMS-907351
Target: Apoptosis, VEGFR, FLT, c-Met/HGFR, c-RET, TAM Receptor, c-Kit
Ensartinib hydrochloride
T22324
Synonym: Ensartinib dihydrochloride,X-396 dihydrochloride
Target: Others, Trk receptor, c-Met/HGFR, ALK
1 2
Cat No. Product Name Synonyms Targets
T13108 Pamufetinib H2OL3Q4XRD,4-(2-Fluoro-4-(3-(2-phenylacetyl)thioureido)phenoxy)-7-methoxy-N-methylquinoline-6-carboxamide,TAS-115 VEGFR , c-Met/HGFR
Pamufetinib (TAS-115) is a potent inhibitor of VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase(IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively).

Recombinant Proteins

Cat No. Product Name Species Expression System
TMPY-01896 HGFR/c-Met Protein, Mouse, Recombinant (His) Mouse HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPY-01296 HGFR/c-Met Protein, Human, Recombinant (His) Human HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPY-01895 HGFR/c-Met Protein, Mouse, Recombinant (hFc) Mouse HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPY-00548 HGFR/c-Met Protein, Cynomolgus, Rhesus, Recombinant (His) Cynomolgus,Rhesus HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPY-05441 HGFR/c-Met Protein, Human, Recombinant (hFc) Human HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPY-00718 HGFR/c-Met Protein, Human, Recombinant (His & hFc) Human HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPY-05607 HGFR/c-Met Protein, Human, Recombinant (His & Avi), Biotinylated Human HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPY-04379 HGFR/c-Met Protein, Human, Recombinant (aa 956-1390, His & GST) Human Baculovirus-Insect Cells
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPY-03581 HGFR/c-Met Protein, Rat, Recombinant (hFc) Rat HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPY-00634 HGFR/c-Met Protein, Cynomolgus, Rhesus, Recombinant Cynomolgus,Rhesus HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPY-06657 HGFR/c-Met Protein, Rat, Recombinant (His) Rat HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPY-02068 HGFR/c-Met Protein, Canine, Recombinant (His) Canine HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPK-00499 HGFR/c-Met Protein, Cynomolgus, Recombinant (His) Cynomolgus HEK293
c-Met, also called tyrosine-protein kinase Met or hepatocyte growth factor receptor (HGFR), is a protein that in humans is encoded by the MET gene.The protein possesses tyrosine kinase activity. The primary single chain ...
TMPK-00457 HGFR/c-Met Protein, Human, Recombinant (His & Avi) Human HEK293
c-Met, also called tyrosine-protein kinase Met or hepatocyte growth factor receptor (HGFR), is a protein that in humans is encoded by the MET gene.The protein possesses tyrosine kinase activity. The primary single chain ...
TMPY-00546 HGFR/c-Met Protein, Cynomolgus, Rhesus, Recombinant (hFc) Cynomolgus,Rhesus HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPY-06278 HGFR/c-Met Protein, Cynomolgus, Rhesus, Recombinant (His), Biotinylated Cynomolgus,Rhesus HEK293
Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR...
TMPJ-00415 HGFR/c-Met Protein, Human, Recombinant (aa 25-932, His & Avi), Biotinylated Human Human Cells
Hepatocyte growth factor receptor (HGF R) is a glycosylated receptor tyrosine kinase that plays a central role in epithelial morphogenesis and cancer development. HGF R is synthesized as a single chain precursor which un...
HGFR/c-Met Protein, Mouse, Recombinant (His)
TMPY-01896
Species: Mouse
Expression System: HEK293
HGFR/c-Met Protein, Human, Recombinant (His)
TMPY-01296
Species: Human
Expression System: HEK293
HGFR/c-Met Protein, Mouse, Recombinant (hFc)
TMPY-01895
Species: Mouse
Expression System: HEK293
HGFR/c-Met Protein, Cynomolgus, Rhesus, Recombinant (His)
TMPY-00548
Species: Cynomolgus,Rhesus
Expression System: HEK293
HGFR/c-Met Protein, Human, Recombinant (hFc)
TMPY-05441
Species: Human
Expression System: HEK293
HGFR/c-Met Protein, Human, Recombinant (His & hFc)
TMPY-00718
Species: Human
Expression System: HEK293
HGFR/c-Met Protein, Human, Recombinant (His & Avi), Biotinylated
TMPY-05607
Species: Human
Expression System: HEK293
HGFR/c-Met Protein, Human, Recombinant (aa 956-1390, His & GST)
TMPY-04379
Species: Human
Expression System: Baculovirus-Insect Cells
HGFR/c-Met Protein, Rat, Recombinant (hFc)
TMPY-03581
Species: Rat
Expression System: HEK293
HGFR/c-Met Protein, Cynomolgus, Rhesus, Recombinant
TMPY-00634
Species: Cynomolgus,Rhesus
Expression System: HEK293
HGFR/c-Met Protein, Rat, Recombinant (His)
TMPY-06657
Species: Rat
Expression System: HEK293
HGFR/c-Met Protein, Canine, Recombinant (His)
TMPY-02068
Species: Canine
Expression System: HEK293
HGFR/c-Met Protein, Cynomolgus, Recombinant (His)
TMPK-00499
Species: Cynomolgus
Expression System: HEK293
HGFR/c-Met Protein, Human, Recombinant (His & Avi)
TMPK-00457
Species: Human
Expression System: HEK293
HGFR/c-Met Protein, Cynomolgus, Rhesus, Recombinant (hFc)
TMPY-00546
Species: Cynomolgus,Rhesus
Expression System: HEK293
HGFR/c-Met Protein, Cynomolgus, Rhesus, Recombinant (His), Biotinylated
TMPY-06278
Species: Cynomolgus,Rhesus
Expression System: HEK293
HGFR/c-Met Protein, Human, Recombinant (aa 25-932, His & Avi), Biotinylated
TMPJ-00415
Species: Human
Expression System: Human Cells
TargetMol